Toronto Wolfpack on the CBD prowl with new Howl product

CDB-infused cream meant to ease aches and pains of athletes and others, expected to be launched in Canada after topicals become legal

Comments

The Toronto Wolfpack has announced it is releasing a line of CBD-infused topical creams, a move the rugby club believes is a first among Canadian professional sports organizations.

The club, which competes in England’s Rugby Football League, announced it is entering the growing CBD product market with Rugby Strength, a series of creams intended to soothe acute aches and pains. To be sold under the Howl brand, a subsidiary of the Wolfpack, the creams will contain no THC, so they will not cause psychoactive effects in consumers.

Wolfpack majority owner David Argyle tells The GrowthOp the product is expected to launch in the U.K. and the U.S. this summer. In Canada, cannabis-infused topical creams have not yet been legalized, but the federal government has promised that related regulations will be in place by mid-October. Once this is the case, Argyle says the Canadian launch of the product will soon follow.

Freedom to try new things

Though the product is under a sports team’s banner, Argyle says the creams will help more than just rugby players. “In rugby, we know a thing or two about pain,” he says. “It if works for us, it could work for you.”

The club, which produces its own matches, is not the first professional sports team to affiliate itself with cannabis products. The Las Vegas Lights, a U.S. pro soccer team, partnered with a Las Vegas cannabis dispensary last year.

First-hand view of how CBD can provide relief

Argyle says he has personally used CBD to treat residual aches and pains from his 20-year-long rugby career. His experience with CBD has made him confident that cannabis-infused products are effective pain relievers, he says.

“When I was playing competitive rugby, we didn’t have an arsenal of ways we could deal with pain and inflammation,” he notes.

“CBD is a great additional weapon to use in managing those issues,” says Argyle.

Dr. Marcus Gitterle, a specialist in regenerative medicine, chief medical officer of WoundCentrics, LLC and scientific advisor to Howl’s development team tells The Growth-Op that CBD topical cream is an effective, easy-to-use pain reliever and anti-inflammatory. “CBD has unique receptor and non-receptor mediated pain modulation properties,” explains Dr. Gitterle. “It’s able to downgrade some of the chemical signals that would lead to later signs of inflammation.”

Rugby Strength is expected to hit shelves in the U.S. and the U.K. this summer. Handout

CBD is “not a replacement for pharmaceuticals,” but he advises it “can fold right in as a complement to conventional medicine.”

Calling CBD “a proven, safe, rational means of doing self-supported care,” Dr. Gitterle says his “hope is that it will see growing acceptance in that role.”

Adds Argyle, “We want to help in not only elevating the benefits of CBD, but also create some dialogue that will lead to more education on the benefits of plant-based medicine.”

 

Want to keep up to date on what’s happening in the world of cannabis?  Subscribe to the Cannabis Post newsletter for weekly insights into the industry, what insiders will be talking about and content from across the Postmedia Network.